New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2013
06:49 EDTBDSIBioDelivery Sciences upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray upgraded BioDelivery Sciences citing the competitive position of the company's chronic pain treatment BBCP. The firm raised its price target for shares to $8 from $5.
News For BDSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 10, 2014
10:01 EDTBDSIOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:02 EDTBDSIBioDelivery Sciences downgraded to Neutral from Buy at Roth Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use